Institut Catala dOncologia ICO - Hospital Duran i Reynals Location

Barcelona 199203

0 studies enrolling now · 4 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumors, Gastrointestinal (GI) Malignancies, Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• Study of INCA 0186 in Subjects With Advanced Solid Tumors — Stopped early
• A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors — Completed